DIRS.INFO The most relevant business & tech news

☆ This biotech startup is finding new cancer drugs with $75 million from General Catalyst. Here's the pitch deck Georgiamune used to raise its Series A.
▼ + stars: | 2024-03-26 | by ( Rebecca Torrence | ) www.businessinsider.com time to read: +4 min

Then, at the Georgia Cancer Center at Augusta University, he began the research that would eventually spin off into his first startup, Georgiamune. The same month, Georgiamune also got FDA clearance to begin human clinical trials for its first cancer drug candidate. Georgiamune's primary drug target works to solve a problem posed by another type of cancer drug on the market, called checkpoint inhibitors. For a Series A biotech startup, Georgiamune has an unusually extensive pipeline, with nine biological targets identified internally, all of which use different mechanisms of action than existing drugs. AdvertisementHere's the 21-slide pitch deck Georgiamune used to raise a $75 million Series A co-led by General Catalyst.

Persons: —, Samir Khleif, King, Khleif, Catalyst, CJNV BioVenture, Georgiamune, doesn't, Amy Abernethy, Khleif's, General Catalyst Organizations: Service, King Hussein Cancer Center, Georgia Cancer Center, Augusta University, Business, Parker Institute for Cancer, Mubadala, Alexandria Venture Investments, Catalio Capital Management, Verition Fund Management, Bicara Therapeutics, Therapeutics, General Locations: Jordan, Verily

☆ Alphabet's Verily lays off employees working in one of its science groups
▼ + stars: | 2024-03-22 | by ( Hugh Langley | ) www.businessinsider.com time to read: +2 min

Verily, the life sciences group owned by Alphabet, laid off staff this week as part of a restructuring in its molecular sciences group, Business Insider has learned. Verily spokesperson Steven Cooper confirmed the cuts in an email to BI, stating that the affected employees worked on Verily's Immune Profiler project, which studies the human immune system for improving disease management. He declined to share the exact number of employees cut, but one source familiar with the situation said 35-40 people were affected. Verily is in the process of separating from Alphabet's infrastructure, part of a project named Flywheel that BI first reported on in 2021. It has set the end of 2024 as the deadline for detachment, a person familiar with the project told BI.

Persons: Verily, Steven Cooper, Cooper, Stephen Gillett, Andy Conrad, Amy Abernethy, Stat, Myoung Cha Organizations: Business, Apple Health

☆ In leaked memo, Google's controversial, visionary healthcare executive Andy Conrad lays out Verily's challenges and a path toward independence: 'I have drifted away from my true passion.'
▼ + stars: | 2022-09-09 | by ( Hugh Langley | ) www.businessinsider.com time to read: +8 min

"Verily is increasingly becoming a more commercial-stage company," Conrad told employees. "I've come to realize that I have drifted away from my true passion — science," Conrad said in the memo. "So at the New Year I want to move away from running the company day to day to concentrate on projects for which I have a deep interest and can contribute in a meaningful way." Insider previously reported that Conrad had taken a step back from day-to-day responsibilities as Gillett had increasingly absorbed more leadership responsibilities. Conrad said the company would search for a new CFO "with a deep healthcare background for the next phase of our growth."

Search resuls for: "Amy Abernethy"

3 mentions found